Member login

Temel Göstergeler


Turkish Pharmaceutical Market

Turkish Pharmaceutical Market (ex-factory prices)

The Turkish pharmaceutical market reached 37,8 billion Turkish Liras (TL) in the last 12 months as of September 2019. During the same period unit sales reached 2,3 billion units.

Source: IQVIA, IEIS

Generic vs. Originator Drugs

Source: IQVIA,IEIS

Source: IQVIA,IEIS

Market Share of Generic vs Originator Drugs


Source: IQVIA,IEIS

Import-Local Products

Source: IQVIA, IEIS

Source: IQVIA, IEIS

Market Share - Local vs. Imports


Source: IQVIA, IEIS

Pharmaceutical Consumption by Therapeutic Class

Pharmaceutical Consumption in Value Terms by Therapeutical Class

Oncology represented the largest proportion by value, accounting for 12,9% of the total market. 

Source: IQVIA, IEIS

Pharmaceutical Consumption in Volume Terms by Therapeutical Class

Antibiotics and anti-rheumatism medicines represented the largest proportion by volume , accounting for 11 % of the total market.

Source: IQVIA, IEIS

Biotechnological Products

Biotechnological products constituted 17,2% of prescription products with 6,5 billion TL and 28,9 million units in the last 12 months as of September 2019. The reference biotechnological pharmaceutical market grew by 15,4% to total 5,9 billion TL. Biosimilar drugs market increased by 87,6% and reached 528,3 million TL.
 

Source: IQVIA, IEIS

Source: IQVIA, IEIS

Foreign Trade

Pharmaceutical exports reached $1218 million in the last 12 months as of September 2019.

Source:TurkStat, IEIS